Helen K Chew

Helen K Chew

UNVERIFIED PROFILE

Are you Helen K Chew?   Register this Author

Register author
Helen K Chew

Helen K Chew

Publications by authors named "Helen K Chew"

Are you Helen K Chew?   Register this Author

27Publications

565Reads

32Profile Views

Preclinical Development and First-in-Human Imaging of the Integrin αβ with [F]αβ-Binding Peptide in Metastatic Carcinoma.

Clin Cancer Res 2019 Feb 6;25(4):1206-1215. Epub 2018 Nov 6.

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis, Davis and Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377828PMC
February 2019

Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancer.

Cancer Treat Res Commun 2018 13;16:38-44. Epub 2018 Jun 13.

Department of Internal Medicine, Division of Hematology Oncology, UC Davis School of Medicine, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2018.06.001DOI Listing
June 2018

Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study.

J Cancer Surviv 2018 06 9;12(3):388-397. Epub 2018 Feb 9.

Center for Oncology Hematology Outcomes Research and Training (COHORT) and Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-018-0678-8DOI Listing
June 2018

SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.

J Clin Oncol 2015 Jan 24;33(1):58-64. Epub 2014 Nov 24.

George T. Budd, Halle C. F. Moore, Cleveland Clinic, Cleveland; Timothy D. Moore, Mid Ohio Oncology Hematology, Columbus, OH; William E. Barlow, Danika L. Lew, SWOG Statistical Center; Kristine J. Rinn, Swedish Cancer Institute; Julie R Gralow, Seattle Cancer Care Alliance, Seattle, WA; Timothy J. Hobday Mayo Clinic, Rochester, MN; James A. Stewart, Baystate Medical Center, Springfield, MA; Claudine Isaacs, Georgetown University, Washington, DC; Muhammad Salim, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Jonathan K. Cho, University of Hawaii MBCCOP, Honolulu, HI; Kathy S. Albain, Loyola University Chicago, Stritch School of Medicine; Chicago, IL; Helen K. Chew, University of California-Davis, Sacramento, CA; Gary V. Burton, Louisiana State University Health Sciences Center, Shreveport, LA; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Lawrence E. Flaherty, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Bradley A. McGregor, Willford Hall Medical Center, Lackland Air Force Base; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Livingston, Arizona Cancer Center, Tucson, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.3296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268253PMC
January 2015

Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance).

J Clin Oncol 2014 Dec 27;32(35):3959-66. Epub 2014 Oct 27.

Harold J. Burstein, William T. Barry, Sara M. Tolaney, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Constance T. Cirrincione, Duke University Alliance Statistics and Data Center; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; Helen K. Chew, University of California, Davis, Davis, CA; Diana E. Lake and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Cynthia Ma, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.7941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251959PMC
December 2014

Richter's syndrome with aberrant CD2 and CD4 expression.

J Clin Oncol 2012 Sep 29;30(26):e243-5. Epub 2012 May 29.

University of California, Davis, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.2065DOI Listing
September 2012

Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.

Oncologist 2012 20;17(2):179-87. Epub 2012 Jan 20.

University of Michigan, Division of Hematology/Oncology, 24 Frank Lloyd Wright Drive, Suite A3400, PO Box 483, Ann Arbor, Michigan 48106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286166PMC
June 2012

The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.

Cancer 2010 Jun;116(11):2596-603

Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25004DOI Listing
June 2010

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.

J Clin Oncol 2010 Apr 11;28(10):1671-6. Epub 2010 Jan 11.

Loyola University Medical Center, Cardinal Bernardin Cancer Center, 2160 S First Ave, Maywood, IL 60153, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.2119DOI Listing
April 2010

Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.

Blood 2009 Apr 16;113(17):3911-7. Epub 2008 Dec 16.

Division of Hematology and Oncology, School of Medicine, University of California San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-08-175745DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673120PMC
April 2009

Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.

Bioinformatics 2009 Jan 9;25(2):251-7. Epub 2008 Dec 9.

Graduate Group in Biostatistics with a Designated Emphasis in Biotechnology, School of Medicine, University of California, Davis, CA 95616, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/bioinformatics/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/bioinformatics/btn610DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639011PMC
January 2009

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.

Clin Breast Cancer 2008 Dec;8(6):511-5

Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510680PMC
December 2008

25th Chemotherapy Foundation Symposium. Innovative Cancer Therapy for Tomorrow. 6-10 November 2007, New York, NY, USA.

Authors:
Helen K Chew

IDrugs 2008 Feb;11(2):90-3

University of California, Davis, Division of Hematology/Oncology, 4501 X Street, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
February 2008

A serum glycomics approach to breast cancer biomarkers.

Mol Cell Proteomics 2007 Jan 17;6(1):43-55. Epub 2006 Jul 17.

Department of Chemistry, University of California, Davis, California 95616, USA.

View Article

Download full-text PDF

Source
http://www.mcponline.org/lookup/doi/10.1074/mcp.M600171-MCP2
Publisher Site
http://dx.doi.org/10.1074/mcp.M600171-MCP200DOI Listing
January 2007

Incidence of venous thromboembolism and the impact on survival in breast cancer patients.

J Clin Oncol 2007 Jan;25(1):70-6

Division of Hematology/Oncology, University of California Davis, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.4393DOI Listing
January 2007

Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment.

Oncol Rep 2006 May;15(5):1299-304

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
May 2006

Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.

J Clin Oncol 2006 Mar;24(7):1112-8

Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.04.2150
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.04.2150DOI Listing
March 2006

Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

Arch Intern Med 2006 Feb;166(4):458-64

Divisionsof Hematology/Oncology, Department of Internal Medicine, and Department of Public Health Sciences, University of California, Davis, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://archinte.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archinte.166.4.458DOI Listing
February 2006

Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.

Arch Intern Med 2005 Aug 8-22;165(15):1782-7

Departments of Internal Medicine, Medicine, Medicine and Statistics, and Public Health Sciences, University of California Davis, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://archinte.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archinte.165.15.1782DOI Listing
September 2005

BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II.

Oncogene 2004 Jul;23(31):5316-29

Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207684DOI Listing
July 2004

Medical management of breast cancer: today and tomorrow.

Authors:
Helen K Chew

Cancer Biother Radiopharm 2002 Apr;17(2):137-49

Breast Cancer Program, Department of Internal Medicine/Division of Hematology/Oncology, University of California Davis Cancer Center, Sacramento, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/108497802753773766DOI Listing
April 2002